AzTrials
AzTrials

OsteoarthritisNCT06228612

Vacuum Therapy and Stabilization Splints Efficacious for the Management of Temporo-mandibular Joint Osteoarthritis

A study testing vacuum therapy, maxillary stabilization splint (MSS) and vacuum therapy VT and maxillary stabilization splint (MSS) in people with Osteoarthritis, run by Mansoura University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study was to determine and compare the clinical efficacy of VT and STT alone or in combination for the patients with temporo-mandibular joint (TMJ) osteoarthritis. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Osteoarthritis
What is being tested?
vacuum therapy, maxillary stabilization splint (MSS) and vacuum therapy VT and maxillary stabilization splint (MSS)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
42 participants
Where
1 siteEgypt
Study dates
20 Jan 2021to 17 Nov 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Inclusion criteria were: (I) clinical diagnosis of TMJ osteoatrhritis according to diagnostic criteria involved in the DC/TMD axis I group 3.A.2 item20 including self-report of TMJ pain, tenderness to palpation, and crepitus (II) magnetic resonance imaging (MRI)signs of joint effusion, erosions and ⁄ or sclerosis of the cortical outline, flattening of the joint surfaces and ⁄ or osteophyte formation ; and (III) age cognitively capable of understanding the standardized questionnaire.

Who cannot join

  • Exclusion criteria were: (I) Patients with systemic disease affecting the joints (II) previous TMJ treatment, (III) previous trauma to TMJ or to the jaws, and (IV) edentulous patients, (V) use of anti-inflammatory drugs at least one month before assessment and during the treatment period.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Fatma A. EL Waseef

    Al Mansurah

Other trials in Egypt

About this study

Official title: How Far Are Vacuum Therapy and Stabilization Splints Efficacious for the Management of Temporo-mandibular Joint Osteoarthritis? A Randomized Clinical Trial.

The aim of this study was to determine and compare the clinical efficacy of VT and STT alone or in combination for the patients with temporo-mandibular joint (TMJ) osteoarthritis.

Read the detailed description

Study design and patients´ selection:

This prospective parallel randomized clinical trial included patients diagnosed with TMJ osteoarthritis. All Patients were collected from the TMD clinic of Prosthodontics Department, Faculty of Dentistry, Mansoura University. The study was approved by the local ethics committee with ethical approval number A12060922. All patients were aware of the treatment procedures and signed informed consents for their participation. Patients were recruited and data collection was performed between . CONSORT guidelines were followed when approperiate19 Inclusion and exclusion criteria were defined prior to the beginning of the study. Inclusion criteria were: (I) clinical diagnosis of TMJ osteoatrhritis according to diagnostic criteria involved in the DC/TMD axis I group 3.A.2 item20 including self-report of TMJ pain, tenderness to palpation, and crepitus (II) magnetic resonance imaging (MRI)signs of joint effusion, erosions and ⁄ or sclerosis of the cortical outline, flattening of the joint surfaces and ⁄ or osteophyte formation ; and (III) age cognitively capable of understanding the standardized questionnaire.

Exclusion criteria were: (I) Patients with systemic disease affecting the joints (II) previous TMJ treatment, (III) previous trauma to TMJ or to the jaws, and (IV) edentulous patients, (V) use of anti-inflammatory drugs at least one month before assessment and during the treatment period.

Sample size calculation:

Sample size calculation was performed by using G*Power software (version 3.1.9.7) based on previous study by El-Shaheed et al.21 A medium effect size (f = 0.25) for interaction effect of treatment group and time on quantitative outcomes (amount of mouth opening in mm, temporo-mandibular joint palpation and VAS score for pain) and a large effect size (f = 0.4) for main group effect on these outcome measures were hypothesised. Based on these assumptions, a total sample size of 42 (14 in each treatment group) achieved 83% power to detect a large effect size (f = 0.4) with 0.05 α-error probability using F test anova: Repeated measures, between factors for three groups and five measurements with a .5 correlation between measurements.

Patients' randomization:

Patients who are eligible in this study after screening phase and who agree to sign the consent form were randomly assigned to grouping. Patient's randomization was performed by two assistants who did not participate in the trial. One assistant had prepared sequentially numbered sealed envelopes with random assignment. The assignment of the treatment was then completed by another assistant from outside the trial. Patients whose treatment plans included vacuum therapy (VT) were designated group (I) and included 14 patients, and those with stabilization splint therapy (SST) were designated (group (II) and included 14 patients. Patients whose treatment plans included both vacuum therapy and splint therapy (VT + SST) were designated as group (III) and included 14 patients.

Intervention:

The treatments were applied by an experienced dentist, with the necessary training in TMD specialty.

For group (I) (VT group), vacuum therapy was applied over the TMJ. Before intervention, all patients were informed about initial suction sensation and possible appearance of bruising at the application site. Basic vacuum therapy equipment (cangexia, China) was utilized including a manual suction pump, plastic cups of 40 mm diameter with rolled edge, and anti-septic tools. The cup can be fixed by means of fixation gel () before application of the cup as hair might interfere with the cup peripheral seal. Dry vacuum therapy was accomplished by application of constant negative pressure of 300 mbar (which is equal to two suctions) using the manual suction pump through the suction cup over the TMJ region for 5 minutes22 (Fig.1). Whether any extra oral muscle showed pain, vacuum therapy application was performed using the same protocol. After completing the procedures, an anti-septic solution was placed over the vacuum application site (sites). All patients in this group were treated one session per week for four successive weeks (Fig.2).

For group (II) (ST group), A maxillary stabilization splint (MSS) was constructed for each patient from hard, heat-cured clear acrylic resin and fitted to the maxillary teeth. On the mounted master casts, the vertical dimension was adjusted to provide 3 mm of vertical space between the closest opposing cusps of the maxillary and mandibular teeth. The occlusal contact of the splint was adjusted to provide even simultaneous contact with the opposing mandibular cusps in the treatment position. the mandibular canines provide laterotrusive guidance in lateral exertions (canine guidance), and mandibular anterior teeth provide anterior contact and posterior disocclusion (anterior guidance). After processing, the splint was fitted on the maxillary arch and adjusted if needed (Fig.3). Patients were advised to wear it 12 hours per day for six months. Patients were recalled regularly for occlusal readjustment of the splint.

For group (III) (VT+SST), both VT and SST were started at the same day. Procedures were the same as in group I and II.

Collagen hydrolysate

Patients' evaluation:

Patients' evaluation was performed by an experienced independent researcher who did not participate in other procedures in this study and was blinded to all intervention groups.

I- Clinical evaluation:

Patients were evaluated regarding their TMJ signs and symptoms at base line (T0), one week (Tw), one month (T1), three months (T3), and six months (T6):

  1. Maximum comfortable mouth opening (MCO) was measured using millimeter ruler between the incisal edges plus the overbite while the patient opens at maximum comfortable opening.
  2. The degree of pain was evaluated using 0 to10 mm Visual Analogue Scale (VAS) for pain (where 0 equals no pain and 10 is the most severe pain).
  3. TMJ tenderness on palpation was assessed by Verbal Rating Scale (VRS) using firm and constant pressure of half kg lasted two seconds over the condyle in front of the tragus. The degree of joint tenderness was extended from 0 to 3 (0: no; 1: slight; 2: moderate; 3: severe).
  4. Joint sound was detected using stethoscope
  5. Change perception was assessed at Tw, T1, T3, and T6 with the Patient Global Impression of Change Scale (PGICS) which evaluates the change perceived by the patients after treatment. This scale has seven affirmations depicting a patient's rating of overall improvement (1 "very much improved", 2 "much improved", 3 "minimally improved", 4 "no change", 5 "minimally worse", 6 "much worse", or 7 "very much worse").
  6. Any side effects from either treatments also had been reported.
Conditions
Osteoarthritis
Being tested
vacuum therapy, maxillary stabilization splint (MSS), vacuum therapy VT and maxillary stabilization splint (MSS)
Keywords
TMJ, osteoarthritis, vacuum, stabilization splint.
Medical subject headings
Osteoarthritis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • vacuum therapyDevice

    vacuum therapy :all patients were informed about initial suction sensation and possible appearance of bruising at the application site. Basic vacuum therapy equipment (cangexia, China) was utilized including a manual suction pump, plastic cups of 40 mm diameter with rolled edge, and anti-septic tools.

  • maxillary stabilization splint (MSS)Device

    maxillary stabilization splint (MSS): was constructed for each patient from hard, heat-cured clear acrylic resin and fitted to the maxillary teeth. On the mounted master casts, the vertical dimension was adjusted to provide 3 mm of vertical space between the closest opposing cusps of the maxillary and mandibular teeth.

  • vacuum therapy VT and maxillary stabilization splint (MSS)Device

    vacuum therapy VT and maxillary stabilization splint (MSS): both Basic vacuum therapy and maxillary stabilization splint :Procedures were the same as in group I and II.

Study groups in NCT06228612
Study groupRoleWhat they receive
group I:vacuum therapyActive comparatorgroup I:vacuum therapy VT:patients who were diagnosed with TMJ osteoarthritis. The patients received Isolated vacuum therapy VT
Receives: Device: vacuum therapy
group II: maxillary stabilization splint (MSS)Active comparatorgroup II, patients who were diagnosed with TMJ osteoarthritis. The patients received stabilization splint therapy (STT)
Receives: Device: maxillary stabilization splint (MSS)
group III: vacuum therapy VT and maxillary stabilization splint (MSS)Active comparatorgroup III: patients who were diagnosed with TMJ osteoarthritis. The patients received combined VT and SST.
Receives: Device: vacuum therapy VT and maxillary stabilization splint (MSS)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximum comfortable mouth opening (MCO),

    Maximum comfortable mouth opening (MCO) was measured using millimeter ruler between the incisal edges plus the overbite while the patient opens at maximum comfortable opening.

    Measured: 6 months

Secondary outcomes (1)
  1. visual analogue scale (VAS),

    The degree of pain was evaluated using 0 to10 mm Visual Analogue Scale (VAS) for pain (where 0 equals no pain and 10 is the most severe pain).

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2024
  2. Study start20 Jan 2021
  3. Primary completion3 Dec 2022
  4. Study completion17 Nov 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Patient's randomization was performed by two assistants who did not participate in the trial. One assistant had prepared sequentially numbered sealed envelopes with random assignment. The assignment of the treatment was then completed by another assistant from outside the trial. Patients whose treatment plans included vacuum therapy (VT) were designated group (I) and included 14 patients, and those with stabilization splint therapy (SST) were designated (group (II) and included 14 patients. Patients whose treatment plans included both vacuum therapy and splint therapy (VT + SST) were designated as group (III) and included 14 patients.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
42 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06228612
Sponsor's protocol ID
A12060922
Status last verified
Dec 2020
First submitted
13 Dec 2023
Last updated
29 Jan 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing vacuum therapy, maxillary stabilization splint (MSS) and vacuum therapy VT and maxillary stabilization splint (MSS) in people with Osteoarthritis, run by Mansoura University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximum comfortable mouth opening (MCO), (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in